Document is current

Article History

Received: 29 December 2024

Accepted: 13 February 2025

First Online: 10 March 2025

Declarations

:

: Giovanni Paolino received fees from Abbvie, Jannsen-Cilag, Pierre Fabre and UCB. Santo Raffaele Mercuri has been principal investigator in clinical trials sponsored by and/or has received personal fees for participation in advisory board from Abbvie, Almirall, Amgen, Leopharma, Lilly, Jansenn, Novartis, Sanofi and Ucb, outside the submitted work. Alessandra Narcisi has served on advisory boards, received honoraria for lectures and research grants from Almirall, Abbvie, Leo Pharma, Celgene, Eli Lilly, Janssen, Novartis, Sanofi-Genzyme, Amgen and Boehringer Ingelheim. Antonio Costanzo has served as an advisory board member, consultant and has received fees and speaker’s honoraria or has participated in clinical trials for Abbvie, Almirall, Biogen, LEO Pharma, Lilly, Janssen, Novartis, Pfizer, Sanofi Genzyme, and UCB-Pharma. Mario Valenti has been a consultant and/or speaker for Sanofi, Leo Pharma, Eli Lilly, Novartis, Janssen, AbbVie, Sun-Pharma, UCB-pharma, Difa Cooper and Boehringer Ingelheim. Mario Valenti is an Editorial Board member of Dermatology and Therapy and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Gioele Ghezzi and Costanza Falcidia has nothing to disclose.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.